Publications

5600 Results

Two-Year Trends Of Taxane-Induced Neuropathy In Women Enrolled In A Randomized Trial Of Acetyl-L-Carnitine (SWOG S0715)

Authors
DL Hershman;JM Unger;K Crew;C Till;H Greenlee;L Minasian;C Moinpour;DL Lew;L Fehrenbacher;JL Wade;S-F Wong;M Fisch;KS Albain
Journal / Conference
Journal of the National Cancer Institute Jun 1;110(6):669-676; 2018 Jan 18. doi: 10.1093/jnci/djx259. [Epub ahead of print]
Year
2018
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID29361042
PMC
PMC6005110
Study Number(s)
S0715

Drug interaction screening in SWOG Clinical Trials

Authors
D Hertz;R Siden;J Modlin;M Gabel;S-F Wong
Journal / Conference
American Journal of Health-System Pharmacy May 15;75(10):607-612
Year
2018
Research Committee(s)
Multiple sites
PMID
PMID29748299
PMC
PMC6685422

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Authors
JC Byrd;AS Ruppert;NA Heerema;AE Halvorson;M Boyd;E Hoke;MR Smith;JE Godwin;S Couban;TA Fehniger;M Thirman;M Tallman;F Appelbaum;RM Stone;S Robinson;JE Chang;SJ Mandrekar;RA Larson
Journal / Conference
Blood Advances, Jul 24;2(14):1705-1718
Year
2018
Research Committee(s)
Leukemia
PMID
PMID30030269
PMC
PMC6058242
Study Number(s)
C10404

Immediate post TURBT instillation of gemcitabine vs saline for suspected low grade bladder cancer: SWOG S0337

Authors
E Messing;C Tangen;SP Lerner;D Sahasrabudhe;T Koppie;DP Wood;PC Mack;R Svatek;C Evans;K Hafez;D Culkin;T Brand;L Karsh;J Holzbeierlein;SS Wilson;G Wu;M Plets;NJ Vogelzang;IM Thompson
Journal / Conference
JAMA May 8;319(18):1880-1888
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29801011
PMC
PMC6583489
Study Number(s)
S0337

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: results from SWOG S0421

Authors
PN Lara;M Plets;C Tangen;E Gertz;N Vogelzang;M Hussain;P Twardowski;M Garzotto;JP Monk;M Carducci;A Goldkorn;PC Mack;DI Quinn;IM Thompson;M Van Loan
Journal / Conference
Cancer Treatment and Research Communications 16:18-23
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID31298998
PMC
PMC6628720
Study Number(s)
S0421

Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 trial

Authors
CE Kyriakopoulos;Y Chen;M Carducci;G Liu;DF Jarrard;M Eisenberger;Y Wong;N Hahn;M Koli;M Cooney;R Dreicer;N Vogelzang;J Picus;D Shevrin;M Hussain;J Garcia;R DiPaola;C Sweeney
Journal / Conference
Journal of Clinical Oncology Apr 10;36(11):1080-1087; Jan 31:JCO2017753657 [Epub ahead of print]
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29384722
PMC
PMC5891129
Study Number(s)
CTSU/E3805

Using Medicare claims to examine long-term prostate cancer risk of Finasteride on the Prostate Cancer Prevention Trial

Authors
J Unger;D Hershman;C Till;C Tangen;W Barlow;SD Ramsey;P Goodman;IM Thompson
Journal / Conference
Journal of the National Cancer Institute Nov 1;110(11):1208-1215
Year
2018
Research Committee(s)
Cancer Control
PMID
PMID29534197
PMC
PMC6235685
Study Number(s)
SWOG-9217

Report of the relapsed/ refractory cohort of SWOG S0919: a phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia

Authors
A Advani;H Li;L Michaelis;B Medeiros;M Liedtke;A List;K O'Dwyer;M Othus;H Erba;FR Appelbaum
Journal / Conference
Leukemia Research Jan 31;67:17-20
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
S0919

Association of RAS mutations with race in metastatic colorectal cancer:CALGB/SWOG 80405 (ALLIANCE)

Authors
A Sehdev;D Niedzwiecki;A Venook;H-J Lenz;F Innocenti;MR Mahoney;JE Shaw;BN Polite;HS Hochster;JN Atkins;RM Goldberg;RJ Mayer;RL Schilsky;M Bertagnoilli;CD Blanke;B O'Neill
Journal / Conference
Journal of Clinical Oncology 36(suppl 4S; abstr 638); ASCO Gastrointestinal Cancers Symposium 2018 (January 18-20, 2018, San Francisco, CA), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

A phase I/II trial of vorinostat (SAHA) in combination with rituximab-chop in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806

Authors
D Persky;H Li;L Rimsza;P Barr;L Popplewell;C Bane;A Von Gehr;M Leblanc;RI Fisher;SM Smith;JW Friedberg
Journal / Conference
American Journal of Hematology Aug;93(4):486-493; 2017 Dec 20. [Epub ahead of print]
Year
2018
Research Committee(s)
Lymphoma
PMID
PMID29266344
PMC
PMC5842116
Study Number(s)
S0806